Oleuropein and Cancer Chemoprevention: The Link is Hot
AbstractCancer comprises a collection of related diseases characterized by the existence of altered cellular pathways resulting in an abnormal tendency for uncontrolled growth. A broad spectrum, coordinated, and personalized approach focused on targeting diverse oncogenic pathways with low toxicity and economic natural compounds can provide a real benefit as a chemopreventive and/or treatment of this complex disease. Oleuropein, a bioactive phenolic compound mainly present in olive oil and other natural sources, has been reported to modulate several oncogenic signalling pathways. This review presents and critically discusses the available literature about the anticancer and onco-suppressive activity of oleuropein and the underlying molecular mechanisms implicated in the anticarcinogenic and therapeutic effects. The existence of limitations and the promising perspectives of research on this phenolic compound are also critically analyzed and discussed. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Ahmad Farooqi, A.; Fayyaz, S.; Silva, A.S.; Sureda, A.; Nabavi, S.F.; Mocan, A.; Nabavi, S.M.; Bishayee, A. Oleuropein and Cancer Chemoprevention: The Link is Hot. Molecules 2017, 22, 705.
Ahmad Farooqi A, Fayyaz S, Silva AS, Sureda A, Nabavi SF, Mocan A, Nabavi SM, Bishayee A. Oleuropein and Cancer Chemoprevention: The Link is Hot. Molecules. 2017; 22(5):705.Chicago/Turabian Style
Ahmad Farooqi, Ammad; Fayyaz, Sundas; Silva, Ana S.; Sureda, Antoni; Nabavi, Seyed F.; Mocan, Andrei; Nabavi, Seyed M.; Bishayee, Anupam. 2017. "Oleuropein and Cancer Chemoprevention: The Link is Hot." Molecules 22, no. 5: 705.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.